Emerging evidence now suggests that nicotine exacerbates hepatic steatosis triggered by HFD, through increased oxidative stress and hepatocellular apoptosis, decreased phosphorylation (inactivation) of adenosine-5-monophosphate-activated protein kinase and, in turn, up-regulation of sterol response-element binding protein 1-c, fatty acid synthase, and activation of acetyl-coenzyme A-carboxylase, leading to increased hepatic lipogenesis
Figure 2 Mechanistically, nicotine activates AMPK2 in adipocytes, which phosphorylates MAP kinase phosphatase-1 (MKP1) at serine 334, resulting its proteasome-dependent degradation ( 2 -terminal kinase (JNK), which phosphorylates insulin receptor substrate 1 (IRS1) at serine 307
Summary: There is currently no established direct causal link between chewing tobacco and fatty liver disease based on available clinical evidence
In people with NAFLD, particularly those with steatohepatitis or fibrosis, your doctor may advise abstinence or further reduction Diabetes and lipid management : Optimising control of blood glucose and cholesterol levels through medication when necessary Monitoring and follow-up are important components of liver health management
The expression and functional role of nicotinic acetylcholine receptors in rat adipocytes
